粒细胞集落刺激因子动员自体外周血干细胞移植治疗急性心肌梗死的临床研究  

Safety and efficacy of intracoronary transplantation of G-CSF mobilized autologous peripheral blood stem cells in patients with acute myocardial infarction

作　　者：李占全[1] 张明[1] 金元哲 张薇薇[1] 刘莹[1] 袁龙[1] 崔丽杰[1] 刘显智[2] 余宪[3] 胡铁石[4] 

机构地区：[1]辽宁省人民医院辽宁省心血管病医院心内科,沈阳110016 [2]沈阳市中心血站 [3]辽宁省肿瘤医院检验科 [4]辽宁省人民医院辽宁省心血管病医院检验科,沈阳110016

出　　处：《中华心血管病杂志》2006年第2期99-102,共4页Chinese Journal of Cardiology

基　　金：国家"十五"科技攻关课题(2004BAT14B0502)

摘　　要：目的观察经皮经腔冠状动脉内移植自体外周血干细胞(PBSC)治疗急性心肌梗死(AMI)的疗效。方法自2003年11月至2005年1月共入选AMI患者70例,随机分为干细胞移植组和对照组,两组均为35例。干细胞治疗组在常规AMI治疗(药物与介入治疗)基础上应用粒细胞集落刺激因子(GCSF)皮下注射动员自体骨髄干细胞,连用5天,第6天分离外周血干细胞悬液,将采集后的干细胞悬液经OVERTHEWIRE球囊导管中心腔注入梗死相关动脉(IRA),进行外周血干细胞移植;对照组经AMI常规方法(药物与介入)治疗。在外周血干细胞动员、采集及经冠状动脉回输过程中观察其不良反应。两组患者在移植前及移植后6个月应用超声心动图评价左室形态及心功能变化,室壁节段性运动积分;比较两组患者生存率及心脏事件发生率。结果6个月时干细胞移植组心脏收缩末容积(ESV)明显减小[(63.8±23.9)ML比(52.6±20.3)ML,P=0.01],舒张末容积(EDV)无显著性变化[(134.2±36.7)ML比(119.2±30.3)ML,P=0.07];左室射血分数(LVEF)显著增高[(50.0±8.2)%比(57.1±7.8)%,P<0.001];左室壁节段性运动积分指数(WMSI)明显减低[(1.219±0.190)比(1.101±0.118),P<0.001]。对照组介入术前及术后6个月随访ESV、EDV、LVEF及WMSI均无统计学差异(P=0.490、0.259、0.117、0.395)。两组术后6个月生存率及心脏事件发生率无统计学差异。不良反应:在PBSC动员、分离、采集及回输中总的不良反应共25例次,其中动员时不良反应占37.1%(13/35),分离和采集中的不良反应占14.3%(5/35),经冠状动脉回输过程中出现的不良反应占20.0%(7/35)。结论经皮经腔冠状动脉内移植自体PBSC治疗AMI可以在近期有效地减少心肌梗死缺血面积,减轻左室重构,改善心功能。Objective To investigate the safety and efficacy of intracoronary transplantation of G- CSF mobilized autologous peripheral blood stem cells in patients with acute myocardial infarction （ AMI ）. Methods Patients with AMI were randomly assigned to receive intracoronary PBSCs transplantation following bone marrow cells mobilization by granulocyte colony-stimulating factor （300-600 ~g/day subcutaneously for 5 days ） in addition to standard therapy （standard drug therapy and PCI, PBSCs transplantation group, n = 35 ） or standard therapy （ standard drug therapy and PCI, n = 35 ）. One day after G-CSF treatment was finished the patient＇s mononuclear cells were harvested by Baxter CS 3000 blood cell separator in a volume of 57 ml and then transferred into the infarct related artery by occluding the over the wire balloon and infusing artery through balloon center lumen. Complications during intervention and left ventricular function at baseline and 6 months thereafter were monitored. Results No severe side effects of G-CSF treatment could be ohserved. Malignant arrhythmias were not observed either. Left ventricular function was significantly improved 6 months after G-CSF mobilized autologous peripheral blood stem cell transplantation compared to baseline （ glohal left ventricular function ejection fraction： 57. 1 ± 7. 8 vs. 50.0±8.2%,P 〈0.0001; WMSI： 1.101 ±0.118 vs. 1.219 ±0.190, P 〈0.0001; left end-systolic volume： 52. 6 ±20. 3 vs. 63.8 ±23.9 ml, P =0. 01 and left end-diastolic volume： 119. 2 ±30. 3 vs. 134. 2 ± 36. 7 ml, P = 0. 07） while these parameters remained unchanged in the control group. Conclusion The present study demonstrates that G-CSF mobilized autologous intracoronary PBSCs transplantation is a safe and feasible treatment for patients with AMI and global left ventricular function is improved and left ventricular remodeling attenuated at six-month follow-up.

关 键 词：心肌梗塞 造血干细胞移植 粒细胞集落刺激因子 

分 类 号：R542.22[医药卫生—心血管疾病] R733[医药卫生—内科学]